In the article by Linde et al, “Real‐World Associations of Renin–Angiotensin–Aldosterone System Inhibitor Dose, Hyperkalemia, and Adverse Clinical Outcomes in a Cohort of Patients With New‐Onset Chronic Kidney Disease or Heart Failure in the United Kingdom,” which published online November 12, 2019, and appeared in the November 19, 2019 issue of the journal (J Am Heart Assoc. 2019;8:e012655. DOI: 10.1161/JAHA.119.012655), a correction to the supplemental material was needed.
The supplemental material is correct in the HTML version of the article, but an incorrect supplemental PDF has been appended to the article PDF. The PDF appended to the article has now been corrected.
The publisher regrets the error.
The online version of the article has been updated and is available at https://www.ahajournals.org/doi/full/10.1161/JAHA.119.012655
J Am Heart Assoc. 2019;8:e014500 DOI: 10.1161/JAHA.119.014500.